Emily Juzwiak, Ph.D.

Emily Juzwiak is a research scientist I in the Cardiovascular Disease Initiative (CVDi) and Precision Cardiology Lab (PCL) at the Broad Institute of MIT and Harvard. She joined the team in October 2025 and works in the Broad-Bayer collaboration to support the identification and validation of novel therapeutics for cardiovascular diseases.

Before joining the PCL, Juzwiak earned her Ph.D. in cellular and molecular medicine from Johns Hopkins University under the guidance of Hal Dietz. There, Juzwiak investigated the role of steroid hormone receptors in a rare vascular disease called vascular Ehlers-Danlos syndrome.